Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-01-07 @ 3:28 AM
Study NCT ID:
NCT04243434
Status:
UNKNOWN
Last Update Posted:
2020-04-16
First Post:
2019-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Sponsor:
Acrotech Biopharma Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-08-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-10-15
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-17
First Submit QC Date:
None
Study First Post Date:
2020-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-15
Last Update Post Date:
2020-04-16
Last Update Post Date Type:
ACTUAL